Insulet Canada Corporation
Registration:
2
of
2
(2026-02-19
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
To support coverage for the ominpod five automated insulin delivery device under the BC pharmacare regime.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Finances and Budgets, Health, Hospitals
|